Predictors of small-for-gestational-age infants in gestational diabetes mellitus: the impact of metformin use.

Arch Gynecol Obstet · 2025 · PMC12334423 · PMID 40261371

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Furthermore, a systematic review and meta-analysis of seven trials comparing short- and long-term outcomes of metformin versus insulin treatment in GDM reported a relative risk of 1.2 for SGA infants, although this did not reach statistical significance (95% CI, 0.85 to 1.04) [ 24 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.